Detalhe da pesquisa
1.
Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis.
Mult Scler
; 29(1): 81-91, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177896
2.
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.
Mult Scler
; 28(1): 102-110, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33890520
3.
Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis.
Mult Scler
; 27(9): 1364-1373, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33104448
4.
Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
Mult Scler
; 26(11): 1381-1391, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373535
5.
Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Brain
; 141(9): 2605-2618, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169585
6.
Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients.
Mult Scler
; 24(11): 1453-1460, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823223
7.
Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.
Mult Scler
; 24(4): 481-490, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29106327
8.
Longitudinal fibre-specific white matter damage predicts cognitive decline in multiple sclerosis.
Brain Commun
; 6(1): fcae018, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344654
9.
A more unstable resting-state functional network in cognitively declining multiple sclerosis.
Brain Commun
; 4(2): fcac095, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620116
10.
Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis.
Neurology
; 97(8): e794-e802, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099528
11.
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
Neurology
; 97(19): e1898-e1905, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34504023
12.
The sequence of structural, functional and cognitive changes in multiple sclerosis.
Neuroimage Clin
; 29: 102550, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418173
13.
Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance.
J Neurol
; 267(11): 3287-3291, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564152
14.
The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms.
Neurology
; 93(17): e1579-e1586, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551258
15.
Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis.
Neurology
; 93(14): e1348-e1359, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484713
16.
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
Lancet Neurol
; 17(2): 133-142, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275979
17.
Disease activity following pregnancy-related discontinuation of natalizumab in MS.
Neurol Neuroimmunol Neuroinflamm
; 5(1): e424, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29379823
18.
Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants.
Neuroimaging Clin N Am
; 27(2): 205-227, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28391782